Literature DB >> 15752833

An analytical framework for immunization programs in Canada.

L J Erickson1, P De Wals, L Farand.   

Abstract

Recent years have seen an increase in the number of new vaccines available on the Canadian market, and increasing divergence in provincial and territorial immunization programs as jurisdictions must choose among available health interventions with limited funding. We present an analytical framework, which we have developed to assist in the analysis and comparison of potential immunization programs. The framework includes 58 criteria classified into 13 categories, including the burden of disease, vaccine characteristics and immunization strategy, cost-effectiveness, acceptability, feasibility, and evaluability of program, research questions, equity, ethical, legal and political considerations. To date this framework has been utilized in a variety of different contexts, such as to structure expert presentations and reports and to examine the degree of consensus and divergence among experts, and to establish priorities. It can be transformed for a variety of other uses such as educating health professionals and the general public about immunization.

Entities:  

Mesh:

Year:  2005        PMID: 15752833     DOI: 10.1016/j.vaccine.2004.10.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  37 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

2.  Heterogeneity of rotavirus testing and admitting practices for gastroenteritis among 12 tertiary care pediatric hospitals: Implications for surveillance.

Authors:  Julie A Bettinger; Kathryn Wills; Nicole Le Saux; David W Scheifele; Scott A Halperin; Wendy Vaudry
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

3.  Immunization in Canada: a 6-year update.

Authors:  Scott A Halperin; Kiersten Pianosi
Journal:  J Can Chiropr Assoc       Date:  2010-06

4.  Human papillomavirus, vaccines and women's health: questions and cautions.

Authors:  Abby Lippman; Ryan Melnychuk; Carolyn Shimmin; Madeline Boscoe
Journal:  CMAJ       Date:  2007-08-01       Impact factor: 8.262

Review 5.  Hepatitis B immunization strategies: timing is everything.

Authors:  Christopher O Mackie; Jane A Buxton; Sayali Tadwalkar; David M Patrick
Journal:  CMAJ       Date:  2009-01-20       Impact factor: 8.262

6.  The human papillomavirus vaccine: The promise of cervical cancer prevention.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

7.  Gardasil® - The New HPV Vaccine: The Right Product, the Right Time? A Commentary.

Authors:  Joel Lexchin; Neil Arya; Sonal Singh
Journal:  Healthc Policy       Date:  2010-05

8.  Another look at the human papillomavirus vaccine experience in Canada.

Authors:  Catherine L Mah; Raisa B Deber; Astrid Guttmann; Allison McGeer; Murray Krahn
Journal:  Am J Public Health       Date:  2011-08-18       Impact factor: 9.308

9.  Optimizing Canadian public immunization programs: a prescription for action.

Authors:  David W Scheifele; Monika Naus; Natasha S Crowcroft; Simon Dobson; Scott A Halperin; Gordean Bjornson
Journal:  Can J Public Health       Date:  2011 May-Jun

10.  Canadian family physicians' and paediatricians' knowledge, attitudes and practices regarding A(H1N1) pandemic vaccine.

Authors:  Eve Dubé; Vladimir Gilca; Chantal Sauvageau; Nicole Boulianne; François D Boucher; Julie A Bettinger; Shelly McNeil; Ian Gemmill; France Lavoie; Manale Ouakki
Journal:  BMC Res Notes       Date:  2010-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.